Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 5
2004 7
2005 8
2006 8
2007 7
2008 6
2009 7
2010 7
2011 8
2012 10
2013 5
2014 9
2015 15
2016 12
2017 9
2018 18
2019 20
2020 23
2021 31
2022 28
2023 24
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.
Keller MB, Newman D, Alnababteh M, Ponor L, Shah P, Matthews J, Kong H, Andargie T, Park W, Charya A, Luikart H, Aryal S, Nathan SD, Orens JB, Khush KK, Jang M, Agbor-Enoh S. Keller MB, et al. J Heart Lung Transplant. 2024 May 3:S1053-2498(24)01644-9. doi: 10.1016/j.healun.2024.04.064. Online ahead of print. J Heart Lung Transplant. 2024. PMID: 38705500
Third-party virus specific T cells for the treatment of double stranded DNA viral reactivation and PTLD after solid organ transplant.
Khoury R, Grimley MS, Nelson AS, Leemhuis T, Cancelas JA, Cook E, Wang Y, Heyenbruch D, Bollard CM, Keller MD, Hanley PJ, Lutzko C, Pham G, Davies SM, Rubinstein JD. Khoury R, et al. Among authors: keller md. Am J Transplant. 2024 Apr 19:S1600-6135(24)00280-6. doi: 10.1016/j.ajt.2024.04.009. Online ahead of print. Am J Transplant. 2024. PMID: 38643944
Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.
Keller MD, Hanley PJ, Chi YY, Aguayo-Hiraldo P, Dvorak CC, Verneris MR, Kohn DB, Pai SY, Dávila Saldaña BJ, Hanisch B, Quigg TC, Adams RH, Dahlberg A, Chandrakasan S, Hasan H, Malvar J, Jensen-Wachspress MA, Lazarski CA, Sani G, Idso JM, Lang H, Chansky P, McCann CD, Tanna J, Abraham AA, Webb JL, Shibli A, Keating AK, Satwani P, Muranski P, Hall E, Eckrich MJ, Shereck E, Miller H, Mamcarz E, Agarwal R, De Oliveira SN, Vander Lugt MT, Ebens CL, Aquino VM, Bednarski JJ, Chu J, Parikh S, Whangbo J, Lionakis M, Zambidis ET, Gourdine E, Bollard CM, Pulsipher MA. Keller MD, et al. Nat Commun. 2024 Apr 18;15(1):3258. doi: 10.1038/s41467-024-47057-2. Nat Commun. 2024. PMID: 38637498 Free PMC article. Clinical Trial.
Mending RAG2: gene editing for treatment of RAG2 deficiency.
Hicks ED, Keller MD. Hicks ED, et al. Among authors: keller md. Blood Adv. 2024 Apr 9;8(7):1817-1819. doi: 10.1182/bloodadvances.2023012079. Blood Adv. 2024. PMID: 38592712 Free PMC article. No abstract available.
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication.
Keller MD, Schattgen SA, Chandrakasan S, Allen EK, Jensen-Wachspress MA, Lazarski CA, Qayed M, Lang H, Hanley PJ, Tanna J, Pai SY, Parikh S, Berger SI, Gottschalk S, Pulsipher MA, Thomas PG, Bollard CM. Keller MD, et al. Nat Commun. 2024 Mar 29;15(1):2749. doi: 10.1038/s41467-024-47056-3. Nat Commun. 2024. PMID: 38553461 Free PMC article.
Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy.
Adams C, Keller M, Michlitsch JG, Aguayo-Hiraldo P, Chen K, Hossain MZ, Davis A, Park JR, Verneris MR, Gardner RA. Adams C, et al. Among authors: keller m. Transplant Cell Ther. 2024 May;30(5):475-487. doi: 10.1016/j.jtct.2024.02.022. Epub 2024 Mar 4. Transplant Cell Ther. 2024. PMID: 38447751 Review.
Implementation of a tier system for IVIG indications to address IVIG shortage at a tertiary care pediatric medical center.
Roth K, Darwish C, Keller MD, Hammer B, Ahmed-Winston S, Escalante E, Madrigal V, Patrick D, Diab Y, Grant C, Hanisch B, Kahn I, Khan S, Moudgil A, Wistinghausen B. Roth K, et al. Among authors: keller md. Pediatr Blood Cancer. 2024 Apr;71(4):e30871. doi: 10.1002/pbc.30871. Epub 2024 Jan 27. Pediatr Blood Cancer. 2024. PMID: 38279890
Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates.
Balasubramanian S, Richert ME, Kong H, Fu S, Jang MK, Andargie TE, Keller MB, Alnababteh M, Park W, Apalara Z, Sun J, Redekar N, Orens J, Aryal S, Bush EL, Cantu E, Diamond J, Shah P, Yu K, Nathan SD, Agbor-Enoh S. Balasubramanian S, et al. Among authors: keller mb. Am J Respir Crit Care Med. 2024 Mar 15;209(6):727-737. doi: 10.1164/rccm.202306-1064OC. Am J Respir Crit Care Med. 2024. PMID: 38117233
236 results